These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 7111359

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Modification of brain mitochondrial monoamine oxidase activities by hydroxyethylhydrazide of cyanoacetic acid and some other monoamine oxidase inhibitors.
    Baumanis EA, Kalnina IE, Moskvitina TA, Gorkin VZ.
    Biochem Pharmacol; 1977 Jun 01; 26(11):1059-63. PubMed ID: 18152
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibitory effects of ethaverine, a homologue of papaverine, on monoamine oxidase activity in mouse brain.
    Lee SS, Lee JJ, Cheong MJ, Kim YH, Kim Y, Yun YP, Lee CK, Lee MK.
    Biol Pharm Bull; 2001 Jul 01; 24(7):838-40. PubMed ID: 11456127
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of monoamine oxidase by palmatine.
    Lee SS, Kim YH, Lee MK.
    Arch Pharm Res; 1999 Oct 01; 22(5):529-31. PubMed ID: 10549584
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Deamination of dopamine and its 3-O-methylated derivative by human brain monoamine oxidase.
    Roth JA, Feor K.
    Biochem Pharmacol; 1978 Oct 01; 27(11):1606-8. PubMed ID: 697902
    [No Abstract] [Full Text] [Related]

  • 9. Further studies on the inhibition of monoamine oxidation by monoamine oxidase inhibitors.
    Ghosh SK, Guha SR.
    Biochem Pharmacol; 1978 Jan 01; 27(1):112-4. PubMed ID: 619893
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of type A monoamine oxidase by coptisine in mouse brain.
    Ro JS, Lee SS, Lee KS, Lee MK.
    Life Sci; 2001 Dec 28; 70(6):639-45. PubMed ID: 11833714
    [Abstract] [Full Text] [Related]

  • 11. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
    Riederer P, Youdim MB.
    J Neurochem; 1986 May 28; 46(5):1359-65. PubMed ID: 2420928
    [Abstract] [Full Text] [Related]

  • 12. Monoamine oxidase: examination of multiple forms.
    Jain M.
    Life Sci; 1977 Jun 15; 20(12):1925-33. PubMed ID: 329033
    [No Abstract] [Full Text] [Related]

  • 13. Some parameters affecting the activity of monoamine oxidase in purified bovine brain mitochondria.
    Gabay S, Achee FM, Mentes G.
    J Neurochem; 1976 Aug 15; 27(2):415-24. PubMed ID: 9476
    [No Abstract] [Full Text] [Related]

  • 14. Biogenic amine metabolism in Biomphalaria glabrata-II. Monoamine oxidase activity.
    Mermel L, Guchhait RB, Bourgeois JG, Bueding E.
    Comp Biochem Physiol C Comp Pharmacol; 1981 Aug 15; 69(2):227-34. PubMed ID: 6116567
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of type A and B monoamine oxidase by 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines and their N-methylated derivatives.
    Minami M, Maruyama W, Dostert P, Nagatsu T, Naoi M.
    J Neural Transm Gen Sect; 1993 Aug 15; 92(2-3):125-35. PubMed ID: 8369106
    [Abstract] [Full Text] [Related]

  • 16. Psychoactive drug effects and substrate-specificity in intact mitochondrial monoamine oxidase from brain [proceedings].
    Gabay S, Achee FM.
    Psychopharmacol Bull; 1977 Jan 15; 13(1):45-6. PubMed ID: 13452
    [No Abstract] [Full Text] [Related]

  • 17. Quinoline and quninaldine as naturally occurring inhibitors specific for type A monoamine oxidase.
    Naoi M, Nagatsu T.
    Life Sci; 1987 Mar 16; 40(11):1075-82. PubMed ID: 3821373
    [Abstract] [Full Text] [Related]

  • 18. Monoamine oxidase. I. Specificity of some substrates and inhibitors.
    Williams CH.
    Biochem Pharmacol; 1974 Feb 01; 23(3):615-28. PubMed ID: 4822746
    [No Abstract] [Full Text] [Related]

  • 19. Substituted amphetamine derivatives. I. Effect on uptake and release of biogenic monoamines and on monoamine oxidase in the mouse brain.
    Ross SB, Ogren SO, Renyi AL.
    Acta Pharmacol Toxicol (Copenh); 1977 Oct 01; 41(4):337-52. PubMed ID: 579062
    [No Abstract] [Full Text] [Related]

  • 20. Studies on monoamine oxidase (report XXIV). Effect of harmine on monoamine oxidase.
    Yasuhara H.
    Jpn J Pharmacol; 1974 Aug 01; 24(4):523-33. PubMed ID: 4156374
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.